Increased Risk of Acute Lymphoblastic Leukemia in Adult Patients with GSTM1 Null Genetic Polymorphism.

Pharmacogenomics and Personalized Medicine Pub Date : 2022-03-15 eCollection Date: 2022-01-01 DOI:10.2147/PGPM.S356302
Ezeldine K Abdalhabib, Badr Alzahrani, Fehaid Alanazi, Abdulrahman Algarni, Ibrahim Khider Ibrahim, Hozifa A Mohamed, Hassan A Hamali, Abdullah A Mobarki, Gasim Dobie, Muhammad Saboor
{"title":"Increased Risk of Acute Lymphoblastic Leukemia in Adult Patients with GSTM1 Null Genetic Polymorphism.","authors":"Ezeldine K Abdalhabib,&nbsp;Badr Alzahrani,&nbsp;Fehaid Alanazi,&nbsp;Abdulrahman Algarni,&nbsp;Ibrahim Khider Ibrahim,&nbsp;Hozifa A Mohamed,&nbsp;Hassan A Hamali,&nbsp;Abdullah A Mobarki,&nbsp;Gasim Dobie,&nbsp;Muhammad Saboor","doi":"10.2147/PGPM.S356302","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Glutathione S-transferases (GSTT1 and GSTM1) detoxify various endogenous and exogenous compounds and provide cytoprotective role against reactive species. This study aimed to assess the frequency of <i>GSTT1</i>, and <i>GSTM1</i> polymorphisms in newly diagnosed Sudanese adult patients with acute lymphoblastic leukemia (ALL) and to evaluate the association of these polymorphisms with age, gender and type of ALL.</p><p><strong>Patients and methods: </strong>This case-control study included 128 adult Sudanese, untreated newly diagnosed patients with ALL, aged 18 to 74 years and 128 age-gender matched healthy controls. Deletional polymorphisms of <i>GSTT1</i> and <i>GSTM1</i> genes were genotyped through a multiplex polymerase chain reaction (PCR) assay using β-globin gene as an internal positive control.</p><p><strong>Results: </strong>The genotypic frequency of <i>GSTT1</i> null polymorphism was 22.7% in cases and 14.8% in controls (OR = 1.68, P = 0.111). Statistically significant differences were noted in the frequencies of <i>GSTM1</i> null polymorphism in cases and controls (OR = 3.7, P = <0.001). Combined <i>GSTT1</i> null and <i>GSTM1</i> null gene polymorphisms showed statistically significant difference in patients with ALL as compared to controls (OR = 6.5, CI 95% = 1.42-29.74, P < 0.001).</p><p><strong>Conclusion: </strong>Irrespective of age at diagnosis, gender, and phenotype of ALL, GSTM1 null polymorphism either alone or in combination with GSTT1 null polymorphism poses significantly increased risk of developing ALL in adults.</p>","PeriodicalId":509088,"journal":{"name":"Pharmacogenomics and Personalized Medicine","volume":" ","pages":"227-234"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/23/pgpm-15-227.PMC8934168.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenomics and Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/PGPM.S356302","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Purpose: Glutathione S-transferases (GSTT1 and GSTM1) detoxify various endogenous and exogenous compounds and provide cytoprotective role against reactive species. This study aimed to assess the frequency of GSTT1, and GSTM1 polymorphisms in newly diagnosed Sudanese adult patients with acute lymphoblastic leukemia (ALL) and to evaluate the association of these polymorphisms with age, gender and type of ALL.

Patients and methods: This case-control study included 128 adult Sudanese, untreated newly diagnosed patients with ALL, aged 18 to 74 years and 128 age-gender matched healthy controls. Deletional polymorphisms of GSTT1 and GSTM1 genes were genotyped through a multiplex polymerase chain reaction (PCR) assay using β-globin gene as an internal positive control.

Results: The genotypic frequency of GSTT1 null polymorphism was 22.7% in cases and 14.8% in controls (OR = 1.68, P = 0.111). Statistically significant differences were noted in the frequencies of GSTM1 null polymorphism in cases and controls (OR = 3.7, P = <0.001). Combined GSTT1 null and GSTM1 null gene polymorphisms showed statistically significant difference in patients with ALL as compared to controls (OR = 6.5, CI 95% = 1.42-29.74, P < 0.001).

Conclusion: Irrespective of age at diagnosis, gender, and phenotype of ALL, GSTM1 null polymorphism either alone or in combination with GSTT1 null polymorphism poses significantly increased risk of developing ALL in adults.

GSTM1零基因多态性成年患者急性淋巴细胞白血病风险增加
目的:谷胱甘肽s -转移酶(GSTT1和GSTM1)对各种内源性和外源性化合物解毒,并对活性物质提供细胞保护作用。本研究旨在评估新诊断的苏丹成年急性淋巴细胞白血病(ALL)患者中GSTT1和GSTM1多态性的频率,并评估这些多态性与年龄、性别和ALL类型的关系。患者和方法:本病例对照研究包括128名苏丹成年人,未经治疗的新诊断ALL患者,年龄在18至74岁之间,以及128名年龄性别匹配的健康对照。以β-珠蛋白基因为内阳性对照,通过多重聚合酶链反应(PCR)对GSTT1和GSTM1基因的缺失多态性进行基因分型。结果:GSTT1零多态性基因型频率为22.7%,对照组为14.8% (OR = 1.68, P = 0.111)。ALL患者GSTM1空基因多态性频率与对照组比较差异有统计学意义(OR = 3.7, P = GSTT1空基因多态性),ALL患者GSTM1空基因多态性与对照组比较差异有统计学意义(OR = 6.5, CI 95% = 1.42 ~ 29.74, P < 0.001)。结论:与ALL的诊断年龄、性别和表型无关,GSTM1空型多态性单独或与GSTT1空型多态性联合可显著增加成人发生ALL的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书